Source: International Congress 2014 – Predictors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Mansouri, M. H. Boskabady (Kermanshah, Mashad, Islamic Republic Of Iran). Pharmacologic bronchodilation response to salbutamol in COPD patients. Eur Respir J 2014; 44: Suppl. 58, 3614

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Hemodynamic effects of inhaled fenoterol and ipratropium in patients with obstructive pulmonary diseases Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Budesonide augments formoterol-induced bronchodilation of human small airways within minutes Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 More relaxation by deep inhalation of methacholine than exercise-pretoned airways of asthmatic children Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 Airway hyperresponsiveness in patients treated with omalizumab Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 BioPhysical bronchodilator: A new class of respiratory drug Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD Source: International Congress 2014 – Asthma and COPD management Year: 2014 Investigating the interaction between bronchoconstriction and cough in asthma Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 The combination therapy with inhaled tiotropium bromide and indacaterol in COPD improves the peripheral airway function in static and dynamic status Source: International Congress 2014 – Asthma and COPD management Year: 2014 Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Lung deposition analysis of two formulations of fluticasone/salmeterol HFA pMDI in stable asthma patients Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015